Clinical Study of Behavior Problems in Children After Different Anesthesia Methods
NCT ID: NCT02945072
Last Updated: 2024-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
500 participants
INTERVENTIONAL
2018-01-22
2024-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sevoflurane group
general anesthesia will be maintained with sevoflurane
Sevoflurane
Sevoflurane is use to anesthesia maintenance after anesthesia induction (target et 2 Vol% in 50-70% N2O, dose adaptation as required)
TIVA group
general anesthesia will be maintained with total intravenous anesthesia (propofol and remifentanyl)
TIVA
TIVA is use to anesthesia maintenance after anesthesia induction (Propofol 10mg/kg/h, Remifentanil 0.2mcg/kg/min, dose adaptation as required for sufficient anesthesia)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TIVA
TIVA is use to anesthesia maintenance after anesthesia induction (Propofol 10mg/kg/h, Remifentanil 0.2mcg/kg/min, dose adaptation as required for sufficient anesthesia)
Sevoflurane
Sevoflurane is use to anesthesia maintenance after anesthesia induction (target et 2 Vol% in 50-70% N2O, dose adaptation as required)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* operation in general anesthesia in combination with regional anesthesia
* Age 2-10 years
* ASA classification 1 or 2 (without severe basic disease or disability)
Exclusion Criteria
* general anesthesia during the last 3 months before or 4 weeks after the procedure
* PONV prophylaxis with droperidol
* severe known growth factor
* mental pre-existing conditions and behavioral abnormalities
* contraindications for one of the used study medications
* insufficient regional anesthesia
* secondary intervention within of the 4-week follow-up
2 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Children's Hospital, Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philipp Buehler, MD
Role: STUDY_CHAIR
University children hosptial Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Philipp Buehler
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-Nr. 2011-0009
Identifier Type: -
Identifier Source: org_study_id